Consequently, understanding the predictive significance of ILA for EGFR mutations and the prognostic value of EGFR status can assist clinicians and radiologists in improving their understanding and evaluation of the long-term prognosis of patients with NSCLC and ILAs. Here, EGFR is linked to non-small cell lung carcinoma.